S.Korea's Osangjaiel surges on U.S. FDA nod for affiliate's coronavirus test kit

OSANGJAIEL Co

20/04/2020 02:13

** Shares of South Korean coronavirus kit maker Osang
HealthCare's parent Osangjaiel  053980.KQ  surge nearly 30% to
14,600 won
    ** Osang HealthCare on Saturday received U.S. FDA's
Emergency Use Approval (EUA) for its coronavirus test kits 
    ** U.S. President Donald Trump made a request for medical
devices on a call with South Korean President Moon Jae-in in
March  urn:newsml:reuters.com:*:nL3N2C225S
    ** Osang HealthCare and SD BIOSENSOR were due to ship their
coronavirus testing kits capable of performing 600,000 tests
last Tuesday  urn:newsml:reuters.com:*:nL3N2C225S urn:newsml:reuters.com:*:nL3N2C11U9
    ** The U.S. death toll from COVID-19, the disease caused by
the virus, topped 40,552 as of Sunday 
    ** After struggling with the first large outbreak outside of
China, South Korea has largely managed to curb its spread
without lockdowns, helped by a massive testing campaign and
intensive contact tracing
    ** The junior KOSDAQ  .KQ11  was trading up 1.2% as of 1236
GMT


 (Reporting by Heekyong Yang)
 ((Heekyong.Yang@thomsonreuters.com; +82 2 6936 1470;))